IMPLANT SITE RASH

IMPLANT SITE RASH was reported 358 times

IMPLANT SITE RASH is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 267 0.0009
1 Vesicular Monoamine Transporter 2 Inhibitor [EPC] 1 0.0008
2 Androgen [EPC] 7 0.0003
3 gamma-Aminobutyric Acid-ergic Agonist [EPC] 8 0.0001
4 Barbiturate [EPC] 1 0.0001
5 Ester Local Anesthetic [EPC] 4 0.0001
6 Amide Local Anesthetic [EPC] 5 0.0001
7 Nitrofuran Antibacterial [EPC] 1 0.0001
8 Non-Standardized Chemical Allergen [EPC] 4 0.0001
9 Antiarrhythmic [EPC] 5 0.0001
10 Aluminum Complex [EPC] 1 0.0000
11 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
12 Provitamin D2 Compound [EPC] 1 0.0000
13 Sympathomimetic-like Agent [EPC] 1 0.0000
14 Anti-epileptic Agent [EPC] 6 0.0000
15 General Anesthetic [EPC] 1 0.0000
16 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
17 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
18 Methylxanthine [EPC] 1 0.0000
19 Tetracycline-class Drug [EPC] 1 0.0000
20 Aldosterone Antagonist [EPC] 2 0.0000
21 Catecholamine [EPC] 1 0.0000
22 Central Nervous System Stimulant [EPC] 1 0.0000
23 Estrogen [EPC] 2 0.0000
24 Partial Opioid Agonist [EPC] 1 0.0000
25 Acetylcholine Release Inhibitor [EPC] 1 0.0000
26 Atypical Antipsychotic [EPC] 4 0.0000
27 Vitamin C [EPC] 3 0.0000
28 Osmotic Laxative [EPC] 2 0.0000
29 Benzodiazepine [EPC] 4 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 7 0.0000
31 Mood Stabilizer [EPC] 1 0.0000
32 Loop Diuretic [EPC] 2 0.0000
33 Opioid Agonist [EPC] 1 0.0000
34 Platinum-based Drug [EPC] 1 0.0000
35 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
36 Factor Xa Inhibitor [EPC] 1 0.0000
37 Proton Pump Inhibitor [EPC] 2 0.0000
38 Vitamin D [EPC] 1 0.0000
39 beta-Adrenergic Blocker [EPC] 1 0.0000
40 Vitamin B12 [EPC] 1 0.0000
41 Corticosteroid [EPC] 3 0.0000
42 Insulin Analog [EPC] 1 0.0000
43 Platelet Aggregation Inhibitor [EPC] 1 0.0000